Shares of Medidata Solutions (Nasdaq: MDSO), the leading cloud analytic software company for the biotech research space, rallied after beating earnings expectations by one cent and reaffirming its forward guidance. The company reported results of Q2 EPS of $0.24, versus expectations of $0.23. Revenue for the quarter came in at… Read More
Dr. Joe Duarte is Chief Investment Strategist and Editor of Profit Catalyst Alert and Weekly Cash Machine. He has been a professional investor and independent analyst since 1990. He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.
Analyst Articles
This could be the final boarding call for buyers of Ambarella Inc. (Nasdaq: AMBA), a global leader in high-speed video chip technology, as the stock is approaching the top of our recommended buy range of $57 and looks ready to make its way toward the $60-plus area. Turnaround ProceedsI like Ambarella’s… Read More
Bull markets climb a wall of worry. And there is plenty to worry about these days, which suggests that stocks could continue to move higher over the next few weeks and perhaps even months. Read More
It’s time to take profits on the McKesson January 19, 2018 195 LEAPS Call option (MCK_011918C195) after a major gain. I recommended its purchase on May 26, 2016 and the long term option gained 43.9% as of the close of trading on July 14, based on the entry price of… Read More
McKesson Corp. is underappreciated, under the radar and contrarian; which is exactly why I like it. Read More
Shares of The WhiteWave Foods Company (WWAV), a leader in organic and non-GMO food products, are trading significantly higher this morning on news that it received a $12.5 billion all-cash buyout offer from France’s Danone Foods, valuing shares of WhiteWave at $56.25, an 18% premium over its closing price on… Read More
Emergent BioSolutions (NYSE: EBS), a biotech company specializing in vaccines and bioterrorism related products, lost more than 25 percent of its value in one trading day on June 22nd. Details on why this happened and what the future would bring were sketchy at first but are slowly becoming available. Only… Read More
The U.S. stock market has some unfinished business. Two weeks ago in this space I warned that the market was vulnerable to a decline. And I was both right and wrong, all within a few days, as the market crashed and recovered over the space of a week after… Read More
Buy Emergent Biosolutions (EBS) Up to $33. Read More
[from the 06/27/2016 edition of Breakthrough Tech Weekly]I found two stocks in our portfolio that are likely to face some headwinds due to Brexit related issues, Amgen (AMGN) and Bio-rad (BIO), so I recommend their immediate sales.Amgen is especially vulnerable, being a member of the Nasdaq 100 Index,… Read More